Antibody DNA Reagent Scientist 
Drug Discovery World
MAY 25, 2023
DNA Script: SYNTAX DNA printing platform Using the company’s EDS technology, the SYNTAX platform can synthesise up to 96 highly accurate, ready-to-use DNA oligos with maximum lengths of up to 120nt in less than 24 hours in the laboratory. The platform works with the SYNTAX Hi-Fidelity reagent kits for synthesising longer oligos.
Drug Discovery World
AUGUST 19, 2024
Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Whether you are developing next-generation therapeutics like TCR/CAR-T or ADCs, or for use as diagnostic reagents, Fujifilm Wako’s service offers the efficiency and precision required for success.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Discovery World
AUGUST 12, 2024
Traditional hybridoma technology has long struggled with inefficiencies, especially in producing rabbit monoclonal antibodies. Whether you are developing next-generation therapeutics like TCR/CAR-T or ADCs, or for use as diagnostic reagents, Fujifilm Wako’s service offers the efficiency and precision required for success.
Pharmaceutical Technology
FEBRUARY 3, 2023
With scientists fervently developing mRNA vaccines, nucleic acid therapeutics, and viral vector-based gene therapies, clinicians are set to have a growing number of tools available to treat a wide range of conditions, from infectious diseases to genetic disorders and more. The field of genomic medicine has reached a true turning point.
Drug Discovery World
NOVEMBER 30, 2023
The company’s goal is to accelerate functional characterisation and shortenoptimisation time in antibody discovery and t-cell workflows. coli expression systems and is using high-throughput expression pipelines to screen constructs for optimal expression to generate protein and cellular reagents.
Drug Discovery World
JULY 18, 2023
Rolf Turk , Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. Nucleic acid-based diagnostics, which typically require PCR reagents and laboratory equipment, are crucial for identifying, treating, and preventing common infectious diseases.
Drug Discovery World
FEBRUARY 27, 2023
By focusing on workflow simplification and expanded assay capabilities in a state-of-the-art microplate reader, complemented by our optimised reagent technologies, our team has created an all-around high-performing system built for today and the future.”
Expert insights. Personalized for you.
52 
Let's personalize your content